Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Item
http://www.wikidata.org/entity/Q34601522
Functional group/guild modelling of inter-specific pathogen interactions: a potential tool for predicting the consequences of co-infection.Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepaticaHuman schistosomiasisAnalysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.Effective anthelmintic therapy of residents living in endemic area of high prevalence for Hookworm and Schistosoma mansoni infections enhances the levels of allergy risk factor anti-Der p1 IgE.Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus ToxoidHepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.Immuno-evasive tactics by schistosomes identify an effective allergy preventative.Elevated Systemic Levels of Eosinophil, Neutrophil, and Mast Cell Granular Proteins in Strongyloides Stercoralis Infection that Diminish following Treatment.Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven bySchistosoma mansoniinfection in humans
P2860

Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Item
http://www.wikidata.org/entity/Q34601522
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@ast
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@en
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@nl
type
label
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@ast
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@en
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@nl
prefLabel
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@ast
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@en
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Eosinophil activity in Schisto ...... sttreatment with praziquantel.
@en
P2093
P2860
P304
P31
P356
10.1128/CVI.13.5.584-593.2006
P433
P478
P50
P577
P698
P921
P932